메뉴 건너뛰기




Volumn 106, Issue 10, 2015, Pages 1438-1447

Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors

Author keywords

Doxorubicin; Drug distribution; Lansoprazole; Pharmacodynamic markers; Solid tumor

Indexed keywords

CASPASE 3; CASPASE 6; DOXORUBICIN; HISTONE H2AX; HISTONE H2AX GAMMA; LANSOPRAZOLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; PROTON PUMP INHIBITOR; TUMOR MARKER;

EID: 84945424858     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12756     Document Type: Article
Times cited : (41)

References (50)
  • 1
    • 84875722622 scopus 로고    scopus 로고
    • Molecular aspects of cancer cell resistance to chemotherapy
    • Rebucci M, Michiels C. Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol 2013; 85: 1219-26.
    • (2013) Biochem Pharmacol , vol.85 , pp. 1219-1226
    • Rebucci, M.1    Michiels, C.2
  • 3
    • 29344443251 scopus 로고    scopus 로고
    • The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors
    • Primeau AJ, Rendon A, Hedley D, Lilge L, Tannock IF. The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors. Clin Cancer Res 2005; 11: 8782-8.
    • (2005) Clin Cancer Res , vol.11 , pp. 8782-8788
    • Primeau, A.J.1    Rendon, A.2    Hedley, D.3    Lilge, L.4    Tannock, I.F.5
  • 4
    • 84879795835 scopus 로고    scopus 로고
    • Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues
    • Patel KJ, Tredan O, Tannock IF. Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues. Cancer Chemother Pharmacol 2013; 72: 127-38.
    • (2013) Cancer Chemother Pharmacol , vol.72 , pp. 127-138
    • Patel, K.J.1    Tredan, O.2    Tannock, I.F.3
  • 5
    • 84876471485 scopus 로고    scopus 로고
    • Use of molecular biomarkers to quantify the spatial distribution of effects of anticancer drugs in solid tumors
    • Saggar JK, Fung AS, Patel KJ, Tannock IF. Use of molecular biomarkers to quantify the spatial distribution of effects of anticancer drugs in solid tumors. Mol Cancer Ther 2013a; 12: 542-52.
    • (2013) Mol Cancer Ther , vol.12 , pp. 542-552
    • Saggar, J.K.1    Fung, A.S.2    Patel, K.J.3    Tannock, I.F.4
  • 7
    • 84891053440 scopus 로고    scopus 로고
    • The tumor microenvironment and strategies to improve drug distribution
    • Saggar JK, Yu M, Tan Q, Tannock IF. The tumor microenvironment and strategies to improve drug distribution. Front Oncol 2013; 3: 154.
    • (2013) Front Oncol , vol.3 , pp. 154
    • Saggar, J.K.1    Yu, M.2    Tan, Q.3    Tannock, I.F.4
  • 8
    • 84938598513 scopus 로고    scopus 로고
    • Chemotherapy rescues hypoxic tumor cells and induces their reoxygenation and repopulation - an effect that is inhibited by the hypoxia-activated pro-drug TH-302
    • Saggar JK, Tannock IF. Chemotherapy rescues hypoxic tumor cells and induces their reoxygenation and repopulation - an effect that is inhibited by the hypoxia-activated pro-drug TH-302. Clin Cancer Res 2015; 21: 2107-14.
    • (2015) Clin Cancer Res , vol.21 , pp. 2107-2114
    • Saggar, J.K.1    Tannock, I.F.2
  • 9
    • 34447258681 scopus 로고    scopus 로고
    • Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize
    • Fukumura D, Jain RK. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 2007; 101: 937-49.
    • (2007) J Cell Biochem , vol.101 , pp. 937-949
    • Fukumura, D.1    Jain, R.K.2
  • 10
    • 72149101372 scopus 로고    scopus 로고
    • The pK(a) distribution of drugs: application to drug discovery
    • Manallack DT. The pK(a) distribution of drugs: application to drug discovery. Perspect Medicin Chem 2007; 1: 25-38.
    • (2007) Perspect Medicin Chem , vol.1 , pp. 25-38
    • Manallack, D.T.1
  • 11
    • 0034104453 scopus 로고    scopus 로고
    • Resistance mechanisms associated with altered intracellular distribution of anticancer agents
    • Larsen AK, Escargueil AE, Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000; 85: 217-29.
    • (2000) Pharmacol Ther , vol.85 , pp. 217-229
    • Larsen, A.K.1    Escargueil, A.E.2    Skladanowski, A.3
  • 12
    • 36349001899 scopus 로고    scopus 로고
    • Targeting vacuolar H+-ATPases as a new strategy against cancer
    • Fais S, De Milito A, You H, Qin W. Targeting vacuolar H+-ATPases as a new strategy against cancer. Cancer Res 2007; 67: 10627-30.
    • (2007) Cancer Res , vol.67 , pp. 10627-10630
    • Fais, S.1    De Milito, A.2    You, H.3    Qin, W.4
  • 13
    • 84919390069 scopus 로고    scopus 로고
    • V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells
    • Schempp CM, von Schwarzenberg K, Schreiner L et al. V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells. Mol Cancer Ther 2014; 13: 926-37.
    • (2014) Mol Cancer Ther , vol.13 , pp. 926-937
    • Schempp, C.M.1    von Schwarzenberg, K.2    Schreiner, L.3
  • 15
    • 0028282608 scopus 로고
    • H(+)-ATPases of renal cortical and medullary endosomes are differentially sensitive to Sch-28080 and omeprazole
    • Sabolic I, Brown D, Verbavatz JM, Kleinman J. H(+)-ATPases of renal cortical and medullary endosomes are differentially sensitive to Sch-28080 and omeprazole. Am J Physiol 1994; 266(6 Pt 2): F868-77.
    • (1994) Am J Physiol , vol.266 , Issue.6 , pp. F868-F877
    • Sabolic, I.1    Brown, D.2    Verbavatz, J.M.3    Kleinman, J.4
  • 16
    • 84857749232 scopus 로고    scopus 로고
    • A rationale for the use of proton pump inhibitors as antineoplastic agents
    • De Milito A, Marino ML, Fais S. A rationale for the use of proton pump inhibitors as antineoplastic agents. Curr Pharm Des 2012; 18: 1395-406.
    • (2012) Curr Pharm Des , vol.18 , pp. 1395-1406
    • De Milito, A.1    Marino, M.L.2    Fais, S.3
  • 17
    • 84925534889 scopus 로고    scopus 로고
    • Autophagy modulation: a target for cancer treatment development
    • Duffy A, Le J, Sausville E, Emadi A. Autophagy modulation: a target for cancer treatment development. Cancer Chemother Pharmacol 2015; 75: 439-47.
    • (2015) Cancer Chemother Pharmacol , vol.75 , pp. 439-447
    • Duffy, A.1    Le, J.2    Sausville, E.3    Emadi, A.4
  • 18
    • 84928700976 scopus 로고    scopus 로고
    • Effects of pantoprazole to enhance activity of docetaxel against human tumor xenografts by inhibiting autophagy
    • Tan Q, Joshua A, Saggar J et al. Effects of pantoprazole to enhance activity of docetaxel against human tumor xenografts by inhibiting autophagy. Br J Cancer, 2015; 112: 832-40.
    • (2015) Br J Cancer , vol.112 , pp. 832-840
    • Tan, Q.1    Joshua, A.2    Saggar, J.3
  • 19
    • 84904048411 scopus 로고    scopus 로고
    • Autophagy inhibition improves chemosensitivity in BRAFV600E brain tumors
    • Levy JM, Thompson JC, Griesinger AM et al. Autophagy inhibition improves chemosensitivity in BRAFV600E brain tumors. Cancer Discov 2014; 4: 773-80.
    • (2014) Cancer Discov , vol.4 , pp. 773-780
    • Levy, J.M.1    Thompson, J.C.2    Griesinger, A.M.3
  • 20
    • 84902494027 scopus 로고    scopus 로고
    • Role of autophagy in cisplatin resistance in ovarian cancer cells
    • Wang J, Wu GS. Role of autophagy in cisplatin resistance in ovarian cancer cells. J Biol Chem 2014; 289: 17163-73.
    • (2014) J Biol Chem , vol.289 , pp. 17163-17173
    • Wang, J.1    Wu, G.S.2
  • 21
    • 84901356565 scopus 로고    scopus 로고
    • S100A8 contributes to drug resistance by promoting autophagy in leukemia cells
    • Yang M, Zeng P, Kang R et al. S100A8 contributes to drug resistance by promoting autophagy in leukemia cells. PLoS ONE 2014; 9: e97242.
    • (2014) PLoS ONE , vol.9 , pp. e97242
    • Yang, M.1    Zeng, P.2    Kang, R.3
  • 22
    • 84890662504 scopus 로고    scopus 로고
    • Use of the proton pump inhibitor pantoprazole to modify the distribution and activity of doxorubicin: a potential strategy to improve the therapy of solid tumors
    • Patel KJ, Lee C, Tan Q, Tannock IF. Use of the proton pump inhibitor pantoprazole to modify the distribution and activity of doxorubicin: a potential strategy to improve the therapy of solid tumors. Clin Cancer Res 2013; 19: 6766-76.
    • (2013) Clin Cancer Res , vol.19 , pp. 6766-6776
    • Patel, K.J.1    Lee, C.2    Tan, Q.3    Tannock, I.F.4
  • 23
    • 33645307960 scopus 로고    scopus 로고
    • Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration
    • Lee CM, Tannock IF. Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration. Br J Cancer 2006; 94: 863-9.
    • (2006) Br J Cancer , vol.94 , pp. 863-869
    • Lee, C.M.1    Tannock, I.F.2
  • 24
    • 9744260934 scopus 로고    scopus 로고
    • Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs
    • Luciani F, Spada M, De Milito A et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 2004; 96: 1702-13.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 1702-1713
    • Luciani, F.1    Spada, M.2    De Milito, A.3
  • 25
    • 84886035271 scopus 로고    scopus 로고
    • Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed
    • Ferrari S, Perut F, Fagioli F et al. Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. J Transl Med 2013; 11: 268.
    • (2013) J Transl Med , vol.11 , pp. 268
    • Ferrari, S.1    Perut, F.2    Fagioli, F.3
  • 26
    • 0032978250 scopus 로고    scopus 로고
    • Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors
    • Tunggal JK, Cowan DS, Shaikh H, Tannock IF. Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors. Clin Cancer Res 1999; 5: 1583-6.
    • (1999) Clin Cancer Res , vol.5 , pp. 1583-1586
    • Tunggal, J.K.1    Cowan, D.S.2    Shaikh, H.3    Tannock, I.F.4
  • 27
    • 0040298568 scopus 로고    scopus 로고
    • Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
    • Janicke RU, Sprengart ML, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998; 273: 9357-60.
    • (1998) J Biol Chem , vol.273 , pp. 9357-9360
    • Janicke, R.U.1    Sprengart, M.L.2    Wati, M.R.3    Porter, A.G.4
  • 28
    • 84860612152 scopus 로고    scopus 로고
    • Quantitative immunohistochemistry for evaluating the distribution of Ki67 and other biomarkers in tumor sections and use of the method to study repopulation in xenografts after treatment with paclitaxel
    • Fung AS, Jonkman J, Tannock IF. Quantitative immunohistochemistry for evaluating the distribution of Ki67 and other biomarkers in tumor sections and use of the method to study repopulation in xenografts after treatment with paclitaxel. Neoplasia 2012; 14: 324-34.
    • (2012) Neoplasia , vol.14 , pp. 324-334
    • Fung, A.S.1    Jonkman, J.2    Tannock, I.F.3
  • 29
    • 0036307898 scopus 로고    scopus 로고
    • Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy
    • Tannock IF, Lee CM, Tunggal JK, Cowan DS, Egorin MJ. Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 2002; 8: 878-84.
    • (2002) Clin Cancer Res , vol.8 , pp. 878-884
    • Tannock, I.F.1    Lee, C.M.2    Tunggal, J.K.3    Cowan, D.S.4    Egorin, M.J.5
  • 30
    • 84914105725 scopus 로고    scopus 로고
    • Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy
    • Fais S, Venturi G, Gatenby B. Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy. Cancer Metastasis Rev 2014; 33: 1095-108.
    • (2014) Cancer Metastasis Rev , vol.33 , pp. 1095-1108
    • Fais, S.1    Venturi, G.2    Gatenby, B.3
  • 31
    • 71749102668 scopus 로고    scopus 로고
    • Microenvironmental pH is a key factor for exosome traffic in tumor cells
    • Parolini I, Federici C, Raggi C et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009; 284: 34211-22.
    • (2009) J Biol Chem , vol.284 , pp. 34211-34222
    • Parolini, I.1    Federici, C.2    Raggi, C.3
  • 32
    • 84895552868 scopus 로고    scopus 로고
    • Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin
    • Federici C, Petrucci F, Caimi S et al. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS ONE 2014; 9: e88193.
    • (2014) PLoS ONE , vol.9 , pp. e88193
    • Federici, C.1    Petrucci, F.2    Caimi, S.3
  • 33
    • 84904685127 scopus 로고    scopus 로고
    • Autophagy: detection, regulation and its role in cancer and therapy response
    • Honscheid P, Datta K, Muders MH. Autophagy: detection, regulation and its role in cancer and therapy response. Int J Radiat Biol 2014; 90: 628-35.
    • (2014) Int J Radiat Biol , vol.90 , pp. 628-635
    • Honscheid, P.1    Datta, K.2    Muders, M.H.3
  • 34
    • 84865800743 scopus 로고    scopus 로고
    • Autophagy is a protective mechanism for human melanoma cells under acidic stress
    • Marino ML, Pellegrini P, Di Lernia G et al. Autophagy is a protective mechanism for human melanoma cells under acidic stress. J Biol Chem 2012; 287: 30664-76.
    • (2012) J Biol Chem , vol.287 , pp. 30664-30676
    • Marino, M.L.1    Pellegrini, P.2    Di Lernia, G.3
  • 35
    • 77950501364 scopus 로고    scopus 로고
    • Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism
    • Fais S. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism. J Intern Med 2010; 267: 515-25.
    • (2010) J Intern Med , vol.267 , pp. 515-525
    • Fais, S.1
  • 36
    • 84919430919 scopus 로고    scopus 로고
    • Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma
    • Azzarito T, Venturi G, Cesolini A, Fais S. Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma. Cancer Lett 2015; 356(2 Pt B): 697-703.
    • (2015) Cancer Lett , vol.356 , Issue.2 , pp. 697-703
    • Azzarito, T.1    Venturi, G.2    Cesolini, A.3    Fais, S.4
  • 37
    • 34347207246 scopus 로고    scopus 로고
    • Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species
    • De Milito A, Iessi E, Logozzi M et al. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res 2007; 67: 5408-17.
    • (2007) Cancer Res , vol.67 , pp. 5408-5417
    • De Milito, A.1    Iessi, E.2    Logozzi, M.3
  • 38
    • 77953463274 scopus 로고    scopus 로고
    • pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity
    • De Milito A, Canese R, Marino ML et al. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer 2010; 127: 207-19.
    • (2010) Int J Cancer , vol.127 , pp. 207-219
    • De Milito, A.1    Canese, R.2    Marino, M.L.3
  • 39
    • 84919494190 scopus 로고    scopus 로고
    • Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition
    • 356
    • Zhang B, Yang Y, Shi X et al. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition. Cancer Lett 356; 2(2 Pt B): 704-12.
    • Cancer Lett , vol.2 , Issue.2 , pp. 704-712
    • Zhang, B.1    Yang, Y.2    Shi, X.3
  • 40
    • 84901845630 scopus 로고    scopus 로고
    • Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion
    • Zhang S, Wang Y, Li SJ. Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion. Biochem Biophys Res Commun 2014; 448: 424-9.
    • (2014) Biochem Biophys Res Commun , vol.448 , pp. 424-429
    • Zhang, S.1    Wang, Y.2    Li, S.J.3
  • 41
    • 84455173776 scopus 로고    scopus 로고
    • Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors
    • Spugnini EP, Baldi A, Buglioni S et al. Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors. J Transl Med 2011; 9: 221.
    • (2011) J Transl Med , vol.9 , pp. 221
    • Spugnini, E.P.1    Baldi, A.2    Buglioni, S.3
  • 42
    • 84908135921 scopus 로고    scopus 로고
    • High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors
    • Spugnini EP, Buglioni S, Carocci F et al. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors. J Transl Med 2014; 12: 225.
    • (2014) J Transl Med , vol.12 , pp. 225
    • Spugnini, E.P.1    Buglioni, S.2    Carocci, F.3
  • 43
    • 84964314701 scopus 로고    scopus 로고
    • Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma
    • Papagerakis S, Bellile E, Peterson LA et al. Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma. Cancer Prev Res (Phila) 2014; 7: 1258-69.
    • (2014) Cancer Prev Res (Phila) , vol.7 , pp. 1258-1269
    • Papagerakis, S.1    Bellile, E.2    Peterson, L.A.3
  • 44
    • 84861090758 scopus 로고    scopus 로고
    • Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo
    • Chen M, Huang SL, Zhang XQ et al. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo. J Cell Biochem 2012; 113: 2474-87.
    • (2012) J Cell Biochem , vol.113 , pp. 2474-2487
    • Chen, M.1    Huang, S.L.2    Zhang, X.Q.3
  • 45
    • 79956342935 scopus 로고    scopus 로고
    • Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells
    • Udelnow A, Kreyes A, Ellinger S et al. Omeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cells. PLoS ONE 2011; 6: e20143.
    • (2011) PLoS ONE , vol.6 , pp. e20143
    • Udelnow, A.1    Kreyes, A.2    Ellinger, S.3
  • 46
    • 79958759965 scopus 로고    scopus 로고
    • Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells
    • Marino ML, Fais S, Djavaheri-Mergny M et al. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis 2010; 1: e87.
    • (2010) Cell Death Dis , vol.1 , pp. e87
    • Marino, M.L.1    Fais, S.2    Djavaheri-Mergny, M.3
  • 47
    • 53249121028 scopus 로고    scopus 로고
    • Proton pump inhibitors: an update of their clinical use and pharmacokinetics
    • Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol 2008; 64: 935-51.
    • (2008) Eur J Clin Pharmacol , vol.64 , pp. 935-951
    • Shi, S.1    Klotz, U.2
  • 48
    • 84876811076 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of the proton pump inhibitors
    • Shin JM, Kim N. Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. J Neurogastroenterol Motil 2013; 19: 25-35.
    • (2013) J Neurogastroenterol Motil , vol.19 , pp. 25-35
    • Shin, J.M.1    Kim, N.2
  • 49
    • 84858602107 scopus 로고    scopus 로고
    • Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma
    • Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 21: 418-29.
    • (2012) Cancer Cell , vol.21 , pp. 418-429
    • Provenzano, P.P.1    Cuevas, C.2    Chang, A.E.3    Goel, V.K.4    Von Hoff, D.D.5    Hingorani, S.R.6
  • 50
    • 84927512782 scopus 로고    scopus 로고
    • A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin
    • Brana I, Ocana A, Chen EX et al. A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin. Invest New Drugs 2014; 32: 1269-77.
    • (2014) Invest New Drugs , vol.32 , pp. 1269-1277
    • Brana, I.1    Ocana, A.2    Chen, E.X.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.